Literature DB >> 27230972

A selected review of abstracts from the 20th Annual Meeting of the Society for Neuro-Oncology (SNO).

Marc C Chamberlain1.   

Abstract

20th Annual Meeting of the Society for Neuro-Oncology, San Antonio, TX, USA, 18-22 November 2015 The Society for Neuro-Oncology is the largest neuro-oncology meeting in the USA that meets annually and provides a multiday venue that showcases new brain cancer clinical trial results and basic research primarily pertaining to gliomas. The Society for Neuro-Oncology 2015 meeting comprising one education day, 2 days of premeetings and 3 days of presentation, over 200 oral presentations and 900 abstracts provides an overview of contemporary neuro-oncology that includes metastatic disease of the central nervous system as well as primary brain tumors. This review attempts to highlight select abstracts presented at this year's meeting in a short summary that provides a synopsis of a large and multifaceted meeting.

Entities:  

Keywords:  SNO 2015 abstracts; primary and secondary (metastatic) brain tumors

Year:  2016        PMID: 27230972      PMCID: PMC6042634          DOI: 10.2217/cns-2016-0014

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  1 in total

1.  Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.

Authors:  Deborah T Blumenthal; Thierry Gorlia; Mark R Gilbert; Michelle M Kim; L Burt Nabors; Warren P Mason; Monika E Hegi; Peixin Zhang; Vassilis Golfinopoulos; James R Perry; Do Hyun Nam; Sara C Erridge; Benjamin W Corn; René O Mirimanoff; Paul D Brown; Brigitta G Baumert; Minesh P Mehta; Martin J van den Bent; David A Reardon; Michael Weller; Roger Stupp
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.